top of page

ACCREDITATION

Educational Objectives:

Upon completion of this educational activity, participants should be able to:

  • Describe current screening, diagnosis and management options for patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders

  • Apply optimal treatment strategies for patients with CLD and GI disorders

  • Compare and contrast currently available treatment modalities for CLD and GI disorders

 

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the New Mexico Medical Society (NMMS) through the joint providership of Rehoboth McKinley Christian Health Care Services (RMCHCS) and Focus Medical Communications. RMCHCS is accredited by the NMMS to provide continuing medical education for physicians.

​

Credit Designation:

RMCHCS designates this live activity for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

​

Please note: Certificates of completion will be available to those who complete and submit the program evaluation.

​

Accredited by:

Rehoboth_2021.png

This program is supported by an educational grant from
AbbVie, Janssen Biotech, Inc., Mallinckrodt Pharmaceuticals, Pfizer Inc., and Takeda Pharmaceuticals U.S.A., Inc.

bottom of page